| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | CD8 receptor binding | 1.12e-07 | 9 | 111 | 4 | GO:0042610 | |
| GeneOntologyMolecularFunction | TAP complex binding | 1.12e-07 | 9 | 111 | 4 | GO:0062061 | |
| GeneOntologyMolecularFunction | TAP1 binding | 1.85e-07 | 10 | 111 | 4 | GO:0046978 | |
| GeneOntologyMolecularFunction | TAP2 binding | 1.85e-07 | 10 | 111 | 4 | GO:0046979 | |
| GeneOntologyMolecularFunction | TAP binding | 1.85e-07 | 10 | 111 | 4 | GO:0046977 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.11e-07 | 118 | 111 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | beta-2-microglobulin binding | 4.33e-07 | 12 | 111 | 4 | GO:0030881 | |
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 2.04e-06 | 17 | 111 | 4 | GO:0046703 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 2.53e-06 | 70 | 111 | 6 | GO:0003777 | |
| GeneOntologyMolecularFunction | T cell receptor binding | 4.09e-06 | 20 | 111 | 4 | GO:0042608 | |
| GeneOntologyMolecularFunction | MHC class I protein binding | 2.88e-05 | 32 | 111 | 4 | GO:0042288 | |
| GeneOntologyMolecularFunction | 14-3-3 protein binding | 8.60e-05 | 42 | 111 | 4 | GO:0071889 | |
| GeneOntologyMolecularFunction | threonine-tRNA ligase activity | 9.15e-05 | 3 | 111 | 2 | GO:0004829 | |
| GeneOntologyMolecularFunction | peptide antigen binding | 1.58e-04 | 49 | 111 | 4 | GO:0042605 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYO1G MYO7A KIF21A KIF4A NLRP1 CHD7 DDX11 KIF19 KIF4B DNAH6 DNAH9 HSPA7 | 1.58e-04 | 614 | 111 | 12 | GO:0140657 |
| GeneOntologyMolecularFunction | MHC protein binding | 3.05e-04 | 58 | 111 | 4 | GO:0042287 | |
| GeneOntologyMolecularFunction | GTP-dependent protein binding | 3.11e-04 | 24 | 111 | 3 | GO:0030742 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MRAS KIF21A NLRP1 CHD7 RAB3C DDX11 RHOBTB1 KIF19 RAB32 GFM1 DNAH6 DNAH9 HSPA7 | 3.70e-04 | 775 | 111 | 13 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | MRAS KIF21A NLRP1 CHD7 RAB3C DDX11 RHOBTB1 KIF19 RAB32 GFM1 DNAH6 DNAH9 HSPA7 | 7.78e-04 | 839 | 111 | 13 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | MRAS KIF21A NLRP1 CHD7 RAB3C DDX11 RHOBTB1 KIF19 RAB32 GFM1 DNAH6 DNAH9 HSPA7 | 7.87e-04 | 840 | 111 | 13 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | MRAS KIF21A NLRP1 CHD7 RAB3C DDX11 RHOBTB1 KIF19 RAB32 GFM1 DNAH6 DNAH9 HSPA7 | 7.87e-04 | 840 | 111 | 13 | GO:0016818 |
| GeneOntologyMolecularFunction | retinyl-palmitate esterase activity | 1.07e-03 | 9 | 111 | 2 | GO:0050253 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 5.08e-08 | 8 | 109 | 4 | GO:0002485 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent | 1.28e-06 | 16 | 109 | 4 | GO:0002486 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway | 1.67e-06 | 17 | 109 | 4 | GO:0002484 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib | 1.67e-06 | 17 | 109 | 4 | GO:0002476 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class Ib | 2.13e-06 | 18 | 109 | 4 | GO:0002428 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class I | 2.13e-06 | 18 | 109 | 4 | GO:0042590 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I | 6.05e-06 | 23 | 109 | 4 | GO:0019885 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen | 8.57e-06 | 25 | 109 | 4 | GO:0002483 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation via MHC class Ib | 8.57e-06 | 25 | 109 | 4 | GO:0002475 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous antigen | 2.37e-05 | 32 | 109 | 4 | GO:0019883 | |
| GeneOntologyBiologicalProcess | inner ear development | 6.00e-05 | 253 | 109 | 8 | GO:0048839 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class I | 6.43e-05 | 41 | 109 | 4 | GO:0002474 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated cytotoxicity | 7.08e-05 | 42 | 109 | 4 | GO:0001916 | |
| GeneOntologyBiologicalProcess | threonyl-tRNA aminoacylation | 8.27e-05 | 3 | 109 | 2 | GO:0006435 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation | 9.63e-05 | 139 | 109 | 6 | GO:0019882 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen | 1.20e-04 | 48 | 109 | 4 | GO:0002478 | |
| GeneOntologyBiologicalProcess | ear development | 1.37e-04 | 285 | 109 | 8 | GO:0043583 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated cytotoxicity | 1.77e-04 | 53 | 109 | 4 | GO:0001914 | |
| GeneOntologyBiologicalProcess | negative regulation of cell projection organization | 2.41e-04 | 233 | 109 | 7 | GO:0031345 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous antigen | 2.51e-04 | 58 | 109 | 4 | GO:0019884 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron projection development | 2.79e-04 | 169 | 109 | 6 | GO:0010977 | |
| GeneOntologyBiologicalProcess | sensory organ development | ABR HLA-A HLA-B HLA-C MYO7A WNT9B HLA-H CHD7 DCX LIMK2 CDH1 RPE65 | 4.79e-04 | 730 | 109 | 12 | GO:0007423 |
| GeneOntologyBiologicalProcess | T cell mediated cytotoxicity | 5.17e-04 | 70 | 109 | 4 | GO:0001913 | |
| GeneOntologyBiologicalProcess | uterus development | 5.25e-04 | 30 | 109 | 3 | GO:0060065 | |
| GeneOntologyCellularComponent | MHC class Ib protein complex | 2.60e-08 | 7 | 111 | 4 | GO:0032398 | |
| GeneOntologyCellularComponent | MHC class I protein complex | 1.54e-07 | 10 | 111 | 4 | GO:0042612 | |
| GeneOntologyCellularComponent | MHC class I peptide loading complex | 7.23e-07 | 14 | 111 | 4 | GO:0042824 | |
| GeneOntologyCellularComponent | cis-Golgi network membrane | 1.70e-06 | 17 | 111 | 4 | GO:0033106 | |
| GeneOntologyCellularComponent | phagocytic vesicle membrane | 5.30e-06 | 83 | 111 | 6 | GO:0030670 | |
| GeneOntologyCellularComponent | Golgi medial cisterna | 6.17e-06 | 23 | 111 | 4 | GO:0005797 | |
| GeneOntologyCellularComponent | MHC protein complex | 1.03e-05 | 26 | 111 | 4 | GO:0042611 | |
| GeneOntologyCellularComponent | microtubule associated complex | 2.45e-05 | 161 | 111 | 7 | GO:0005875 | |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 3.47e-05 | 35 | 111 | 4 | GO:0098553 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 7.21e-05 | 42 | 111 | 4 | GO:0070971 | |
| GeneOntologyCellularComponent | cis-Golgi network | 9.02e-05 | 85 | 111 | 5 | GO:0005801 | |
| GeneOntologyCellularComponent | lumenal side of membrane | 1.22e-04 | 48 | 111 | 4 | GO:0098576 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 1.39e-04 | 212 | 111 | 7 | GO:0030666 | |
| GeneOntologyCellularComponent | phagocytic vesicle | 1.93e-04 | 157 | 111 | 6 | GO:0045335 | |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 3.03e-04 | 110 | 111 | 5 | GO:0030134 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 3.29e-04 | 112 | 111 | 5 | GO:0055038 | |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 3.74e-04 | 64 | 111 | 4 | GO:0012507 | |
| GeneOntologyCellularComponent | microtubule | 5.50e-04 | 533 | 111 | 10 | GO:0005874 | |
| GeneOntologyCellularComponent | transport vesicle membrane | 9.71e-04 | 293 | 111 | 7 | GO:0030658 | |
| GeneOntologyCellularComponent | recycling endosome | 1.20e-03 | 222 | 111 | 6 | GO:0055037 | |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | 2.52e-03 | 443 | 111 | 8 | GO:0098791 | |
| GeneOntologyCellularComponent | cytoplasmic region | 3.12e-03 | 360 | 111 | 7 | GO:0099568 | |
| GeneOntologyCellularComponent | membrane raft | 3.21e-03 | 362 | 111 | 7 | GO:0045121 | |
| GeneOntologyCellularComponent | membrane microdomain | 3.31e-03 | 364 | 111 | 7 | GO:0098857 | |
| MousePheno | spinal cord inflammation | 1.26e-07 | 8 | 93 | 4 | MP:0030987 | |
| MousePheno | CNS inflammation | 2.86e-05 | 54 | 93 | 5 | MP:0006082 | |
| Domain | MHC_I_a_C | 1.76e-08 | 6 | 111 | 4 | IPR010579 | |
| Domain | MHC_I_C | 1.76e-08 | 6 | 111 | 4 | PF06623 | |
| Domain | MHC_I | 6.54e-06 | 21 | 111 | 4 | PF00129 | |
| Domain | MHC_I_a_a1/a2 | 6.54e-06 | 21 | 111 | 4 | IPR001039 | |
| Domain | P-loop_NTPase | MYO1G MRAS MYO7A KIF21A KIF4A NLRP1 CHD7 RAB3C DDX11 RHOBTB1 KIF19 KIF4B RAB32 GFM1 DNAH6 DNAH9 | 4.05e-05 | 848 | 111 | 16 | IPR027417 |
| Domain | Kinesin_motor_CS | 1.01e-04 | 41 | 111 | 4 | IPR019821 | |
| Domain | ThrRS_core | 1.05e-04 | 3 | 111 | 2 | IPR033728 | |
| Domain | Thr-tRNA-ligase_IIa | 1.05e-04 | 3 | 111 | 2 | IPR002320 | |
| Domain | Kinesin-like_fam | 1.22e-04 | 43 | 111 | 4 | IPR027640 | |
| Domain | - | 1.34e-04 | 44 | 111 | 4 | 3.40.850.10 | |
| Domain | Kinesin | 1.34e-04 | 44 | 111 | 4 | PF00225 | |
| Domain | KISc | 1.34e-04 | 44 | 111 | 4 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 1.34e-04 | 44 | 111 | 4 | PS00411 | |
| Domain | Kinesin_motor_dom | 1.34e-04 | 44 | 111 | 4 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 1.34e-04 | 44 | 111 | 4 | PS50067 | |
| Domain | C1-set | 2.97e-04 | 54 | 111 | 4 | PF07654 | |
| Domain | IGc1 | 3.42e-04 | 56 | 111 | 4 | SM00407 | |
| Domain | - | 3.78e-04 | 24 | 111 | 3 | 3.30.500.10 | |
| Domain | MHC_I-like_Ag-recog | 3.78e-04 | 24 | 111 | 3 | IPR011161 | |
| Domain | Ig/MHC_CS | 3.92e-04 | 58 | 111 | 4 | IPR003006 | |
| Domain | Ig_C1-set | 3.92e-04 | 58 | 111 | 4 | IPR003597 | |
| Domain | IG_MHC | 4.46e-04 | 60 | 111 | 4 | PS00290 | |
| Domain | TGS | 5.17e-04 | 6 | 111 | 2 | IPR004095 | |
| Domain | TGS | 5.17e-04 | 6 | 111 | 2 | PF02824 | |
| Domain | tRNA_SAD | 7.21e-04 | 7 | 111 | 2 | IPR012947 | |
| Domain | TGS-like | 7.21e-04 | 7 | 111 | 2 | IPR012676 | |
| Domain | tRNA_SAD | 7.21e-04 | 7 | 111 | 2 | SM00863 | |
| Domain | tRNA_SAD | 7.21e-04 | 7 | 111 | 2 | PF07973 | |
| Domain | Thr/Ala-tRNA-synth_IIc_edit | 9.57e-04 | 8 | 111 | 2 | IPR018163 | |
| Domain | HGTP_anticodon | 1.23e-03 | 9 | 111 | 2 | PF03129 | |
| Domain | MHC_I/II-like_Ag-recog | 1.48e-03 | 38 | 111 | 3 | IPR011162 | |
| Domain | aa-tRNA-synt_IIb | 1.86e-03 | 11 | 111 | 2 | IPR002314 | |
| Domain | - | 1.86e-03 | 11 | 111 | 2 | 3.40.50.800 | |
| Domain | tRNA-synt_2b | 1.86e-03 | 11 | 111 | 2 | PF00587 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 2.18e-07 | 9 | 93 | 4 | MM14527 | |
| Pathway | REACTOME_ER_PHAGOSOME_PATHWAY | 5.06e-06 | 18 | 93 | 4 | MM14525 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 5.48e-06 | 6 | 93 | 3 | M47468 | |
| Pathway | BIOCARTA_CTL_PATHWAY | 7.93e-06 | 20 | 93 | 4 | MM1374 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 9.54e-06 | 7 | 93 | 3 | M47582 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 9.54e-06 | 7 | 93 | 3 | M47530 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 2.02e-05 | 25 | 93 | 4 | MM15713 | |
| Pathway | BIOCARTA_NKCELLS_PATHWAY | 2.02e-05 | 25 | 93 | 4 | MM1465 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 3.72e-05 | 29 | 93 | 4 | M1062 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 4.41e-05 | 11 | 93 | 3 | M525 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 5.86e-05 | 12 | 93 | 3 | M47529 | |
| Pathway | PID_ANTHRAX_PATHWAY | 2.11e-04 | 18 | 93 | 3 | M267 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 4.36e-04 | 54 | 93 | 4 | MM14871 | |
| Pathway | REACTOME_KINESINS | 5.37e-04 | 57 | 93 | 4 | MM15714 | |
| Pathway | REACTOME_KINESINS | 6.95e-04 | 61 | 93 | 4 | M977 | |
| Pubmed | 1.38e-10 | 11 | 111 | 5 | 2911572 | ||
| Pubmed | 3.81e-10 | 13 | 111 | 5 | 8835526 | ||
| Pubmed | Meiotic mapping of murine chromosome 17: the string of loci around l(17)-2Pas. | 3.81e-10 | 13 | 111 | 5 | 1794044 | |
| Pubmed | 1.28e-09 | 16 | 111 | 5 | 1799792 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 1705528 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 2808323 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 21088134 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 69663 | ||
| Pubmed | Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense. | 3.41e-09 | 7 | 111 | 4 | 12459592 | |
| Pubmed | Multiple sequences related to classical histocompatibility antigens in the mouse genome. | 3.41e-09 | 7 | 111 | 4 | 6264319 | |
| Pubmed | Sequence analysis of the C3H H-2K1k gene: relationship to the H-2 loci. | 3.41e-09 | 7 | 111 | 4 | 2714856 | |
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 10500200 | ||
| Pubmed | Structural analysis of H-2Kf and H-2Kfm1 by using H-2K locus-specific sequences. | 3.41e-09 | 7 | 111 | 4 | 2391419 | |
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 15671142 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 14215561 | ||
| Pubmed | A saturation hypothesis to explain both enhanced and impaired learning with enhanced plasticity. | 3.41e-09 | 7 | 111 | 4 | 28234229 | |
| Pubmed | Interaction of H-2Db with mutant histocompatibility gene H (KH-11) in the mouse. | 3.41e-09 | 7 | 111 | 4 | 6242891 | |
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 17512611 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 7018573 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 2642506 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 9037062 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 1840571 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 20957233 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 11580250 | ||
| Pubmed | V beta T cell repertoire of CD8+ splenocytes selected on nonpolymorphic MHC class I molecules. | 3.41e-09 | 7 | 111 | 4 | 11086076 | |
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 12750360 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 18416856 | ||
| Pubmed | Convergent recombination shapes the clonotypic landscape of the naive T-cell repertoire. | 3.41e-09 | 7 | 111 | 4 | 20974936 | |
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 10704462 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 22573867 | ||
| Pubmed | A novel H-2K splice form: predictions for other alternative H-2 splicing events. | 3.41e-09 | 7 | 111 | 4 | 2908875 | |
| Pubmed | Comparison of exon 5 sequences from 35 class I genes of the BALB/c mouse. | 3.41e-09 | 7 | 111 | 4 | 2584927 | |
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 3496275 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 12147629 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 3458188 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 19462379 | ||
| Pubmed | Structural diversity of the classical H-2 genes: K, D, and L. | 3.41e-09 | 7 | 111 | 4 | 1730883 | |
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 3680952 | ||
| Pubmed | Thymus leukemia antigen controls intraepithelial lymphocyte function and inflammatory bowel disease. | 3.41e-09 | 7 | 111 | 4 | 19004778 | |
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 6300887 | ||
| Pubmed | H-2-linked regulation of xenotropic murine leukemia virus expression. | 3.41e-09 | 7 | 111 | 4 | 6300850 | |
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 8500526 | ||
| Pubmed | cDNA clone coding for part of a mouse H-2d major histocompatibility antigen. | 3.41e-09 | 7 | 111 | 4 | 6265910 | |
| Pubmed | Cutting edge: MHC class I-Ly49 interaction regulates neuronal function. | 3.41e-09 | 7 | 111 | 4 | 18453559 | |
| Pubmed | DNA polymorphisms defined by the Tu108 probe map to the Tla region of mouse chromosome 17. | 3.41e-09 | 7 | 111 | 4 | 2906539 | |
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 3013627 | ||
| Pubmed | DNA sequence of the mouse H-2Dd transplantation antigen gene. | 3.41e-09 | 7 | 111 | 4 | 3856254 | |
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 3894562 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 27385590 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 1348042 | ||
| Pubmed | H2-K(b) and H2-D(b) regulate cerebellar long-term depression and limit motor learning. | 3.41e-09 | 7 | 111 | 4 | 19346486 | |
| Pubmed | Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells. | 3.41e-09 | 7 | 111 | 4 | 18383043 | |
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 16272298 | ||
| Pubmed | Tissue-specific expression of an unusual H-2 (class I)-related gene. | 3.41e-09 | 7 | 111 | 4 | 6956903 | |
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 8833240 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 21178009 | ||
| Pubmed | Expression and function of transplantation antigens with altered or deleted cytoplasmic domains. | 3.41e-09 | 7 | 111 | 4 | 6604582 | |
| Pubmed | Isolation of a cDNA clone for the murine transplantation antigen H-2Kb. | 3.41e-09 | 7 | 111 | 4 | 6954478 | |
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 34525366 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 3374494 | ||
| Pubmed | Extensive deletions in the Q region of the mouse major histocompatibility complex. | 3.41e-09 | 7 | 111 | 4 | 3025084 | |
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 2543831 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 2989712 | ||
| Pubmed | Unique biochemical properties of a mutant MHC class I molecule, H-2Ksm1. | 3.41e-09 | 7 | 111 | 4 | 1280760 | |
| Pubmed | Three cDNA clones encoding mouse transplantation antigens: homology to immunoglobulin genes. | 3.41e-09 | 7 | 111 | 4 | 6786753 | |
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 6583704 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 6571712 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 9222352 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 12006653 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 1699529 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 17982076 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 7520098 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 15644207 | ||
| Pubmed | How a single T cell receptor recognizes both self and foreign MHC. | 3.41e-09 | 7 | 111 | 4 | 17418792 | |
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 9185075 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 21483793 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 10452993 | ||
| Pubmed | Intestinal epithelial cells modulate CD4 T cell responses via the thymus leukemia antigen. | 3.41e-09 | 7 | 111 | 4 | 21900182 | |
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 15272181 | ||
| Pubmed | Genetic control of scrapie and Creutzfeldt-Jakob disease in mice. | 3.41e-09 | 7 | 111 | 4 | 6408182 | |
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 26714929 | ||
| Pubmed | Partial nucleotide sequence of H-2Dd major histocompatibility antigen gene. | 3.41e-09 | 7 | 111 | 4 | 3925012 | |
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 6280871 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 10799615 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 10993729 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 1339405 | ||
| Pubmed | H-2D(b-/-) mice are susceptible to persistent infection by Theiler's virus. | 3.41e-09 | 7 | 111 | 4 | 10823851 | |
| Pubmed | MHC class I Dk locus and Ly49G2+ NK cells confer H-2k resistance to murine cytomegalovirus. | 3.41e-09 | 7 | 111 | 4 | 19454713 | |
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 10229092 | ||
| Pubmed | Comparison of nucleotide sequences of mRNAs belonging to the mouse H-2 multigene family. | 3.41e-09 | 7 | 111 | 4 | 6278432 | |
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 7295646 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 2879284 | ||
| Pubmed | Structure and expression of a mouse major histocompatibility antigen gene, H-2Ld. | 3.41e-09 | 7 | 111 | 4 | 6952248 | |
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 24064213 | ||
| Pubmed | Developmental Sculpting of Intracortical Circuits by MHC Class I H2-Db and H2-Kb. | 3.41e-09 | 7 | 111 | 4 | 25316337 | |
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 7306483 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 2903482 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 28475642 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 2351932 | ||
| Pubmed | 3.41e-09 | 7 | 111 | 4 | 17240452 | ||
| Interaction | BTNL2 interactions | 2.31e-06 | 155 | 111 | 8 | int:BTNL2 | |
| Interaction | HLA-G interactions | 4.05e-06 | 118 | 111 | 7 | int:HLA-G | |
| Interaction | LILRB1 interactions | 1.90e-05 | 10 | 111 | 3 | int:LILRB1 | |
| Interaction | LILRB2 interactions | 1.90e-05 | 10 | 111 | 3 | int:LILRB2 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 4.65e-05 | 44 | 82 | 4 | 588 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 5.55e-05 | 46 | 82 | 4 | 622 | |
| GeneFamily | C1-set domain containing | 9.09e-04 | 42 | 82 | 3 | 591 | |
| GeneFamily | Dyneins, axonemal | 2.64e-03 | 17 | 82 | 2 | 536 | |
| GeneFamily | DNA helicases | 2.64e-03 | 17 | 82 | 2 | 1167 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN | 1.38e-08 | 19 | 111 | 5 | MM797 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_ENDOTHELIAL_CELL_OF_LYMPHATIC_VESSEL_AGEING | 5.33e-07 | 16 | 111 | 4 | MM3766 | |
| Coexpression | MIKKELSEN_NPC_ICP_WITH_H3K27ME3 | 1.12e-06 | 19 | 111 | 4 | MM862 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_LEUKOCYTE_AGEING | 1.40e-06 | 20 | 111 | 4 | MM3682 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_UP | 1.72e-06 | 21 | 111 | 4 | MM651 | |
| Coexpression | GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP | 2.25e-06 | 200 | 111 | 8 | M9889 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_PULMONARY_INTERSTITIAL_FIBROBLAST_AGEING | 3.03e-06 | 24 | 111 | 4 | MM3773 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP | 3.60e-06 | 25 | 111 | 4 | MM672 | |
| Coexpression | KIM_LRRC3B_TARGETS | 7.67e-06 | 30 | 111 | 4 | M17363 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_MESANGIAL_CELL_AGEING | 8.78e-06 | 31 | 111 | 4 | MM3729 | |
| Coexpression | PAL_PRMT5_TARGETS_DN | 1.44e-05 | 35 | 111 | 4 | MM674 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_GRANULOCYTE_AGEING | 1.59e-05 | 74 | 111 | 5 | MM3796 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_BRUSH_CELL_AGEING | 1.70e-05 | 75 | 111 | 5 | MM3718 | |
| Coexpression | DURAND_STROMA_NS_UP | 1.94e-05 | 194 | 111 | 7 | MM962 | |
| Coexpression | DELYS_THYROID_CANCER_UP | EPHB3 SLC26A3 ABR PSD3 SERPINA1 SV2A APLNR SEL1L3 TNFSF15 ALOX5AP | 2.01e-05 | 445 | 111 | 10 | M3645 |
| Coexpression | TABULA_MURIS_SENIS_LUNG_CD8_POSITIVE_ALPHA_BETA_T_CELL_AGEING | 2.23e-05 | 39 | 111 | 4 | MM3758 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_CORTEX_ARTERY_CELL_AGEING | 2.23e-05 | 39 | 111 | 4 | MM3725 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_UP | 2.36e-05 | 200 | 111 | 7 | M8026 | |
| Coexpression | GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_DN | 2.36e-05 | 200 | 111 | 7 | M4583 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_MACROPHAGE_AGEING | 2.62e-05 | 82 | 111 | 5 | MM3858 | |
| Coexpression | HOWLIN_CITED1_TARGETS_1_UP | 2.73e-05 | 41 | 111 | 4 | MM710 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_MYELOID | 2.86e-05 | 139 | 111 | 6 | M39044 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP | 2.94e-05 | 84 | 111 | 5 | MM1049 | |
| Coexpression | MIKKELSEN_MCV6_ICP_WITH_H3K27ME3 | 3.30e-05 | 86 | 111 | 5 | MM834 | |
| Coexpression | HU_GENOTOXIC_DAMAGE_4HR | 3.31e-05 | 43 | 111 | 4 | MM1204 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_TYPE_II_PNEUMOCYTE_AGEING | 3.63e-05 | 44 | 111 | 4 | MM3775 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_ENDOCARDIAL_CELL_AGEING | 4.33e-05 | 46 | 111 | 4 | MM3712 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | IGSF8 HLA-A HLA-B HLA-C HLA-H PTCH1 ZZEF1 CES2 SLC30A6 SLC9A5 PLXNA1 XPOT | 4.41e-05 | 703 | 111 | 12 | MM1055 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP | HLA-A HLA-B HLA-C WNT9B HLA-H PHYHD1 MYOF PTPN13 SEMA3B CDH1 | 4.55e-05 | 490 | 111 | 10 | MM1001 |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_25_PRECICTIVE_ICB_RESPONSE | 4.99e-05 | 225 | 111 | 7 | MM17079 | |
| Coexpression | BAUS_TFF2_TARGETS_UP | 5.57e-05 | 49 | 111 | 4 | MM1287 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_MACROPHAGE_AGEING | 5.88e-05 | 97 | 111 | 5 | MM3789 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_CELL_AGEING | 6.04e-05 | 50 | 111 | 4 | MM3805 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_NAIVE_T_CELL_AGEING | 7.05e-05 | 52 | 111 | 4 | MM3808 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN | 7.83e-05 | 103 | 111 | 5 | MM476 | |
| Coexpression | IBRAHIM_NRF2_UP | KIF21A NOL10 NAA50 SLC30A6 MRPS30 EDEM3 SEL1L3 GFM1 TARS1 XPOT | 9.13e-05 | 533 | 111 | 10 | M42510 |
| Coexpression | TABULA_MURIS_SENIS_TONGUE_KERATINOCYTE_AGEING | 9.44e-05 | 56 | 111 | 4 | MM3852 | |
| Coexpression | CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP | 9.99e-05 | 174 | 111 | 6 | M2038 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_SMOOTH_MUSCLE_CELL_AGEING | 1.01e-04 | 57 | 111 | 4 | MM3716 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_INTERNEURON_AGEING | 1.16e-04 | 59 | 111 | 4 | MM3688 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_ENDOCARDIAL_CELL_AGEING | 1.16e-04 | 59 | 111 | 4 | MM3704 | |
| Coexpression | DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN | 1.17e-04 | 179 | 111 | 6 | M8519 | |
| Coexpression | WENG_POR_DOSAGE | 1.23e-04 | 23 | 111 | 3 | M1634 | |
| Coexpression | ZHANG_UTERUS_C9_DENDRITIC_CELL | 1.27e-04 | 114 | 111 | 5 | MM16615 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_HEMATOPOIETIC_PRECURSOR_CELL_AGEING | 1.27e-04 | 114 | 111 | 5 | MM3799 | |
| Coexpression | ESC_V6.5_UP_LATE.V1_UP | 1.36e-04 | 184 | 111 | 6 | M2772 | |
| Coexpression | WANG_CISPLATIN_RESPONSE_AND_XPC_UP | 1.40e-04 | 185 | 111 | 6 | M19511 | |
| Coexpression | GSE11386_NAIVE_VS_MEMORY_BCELL_UP | 1.40e-04 | 185 | 111 | 6 | M374 | |
| Coexpression | ANDERSEN_CHOLANGIOCARCINOMA_CLASS1 | 1.50e-04 | 63 | 111 | 4 | M282 | |
| Coexpression | ZHANG_UTERUS_C12_MONOCYTE | 1.53e-04 | 188 | 111 | 6 | MM16618 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 1.78e-04 | 470 | 111 | 9 | MM1053 | |
| Coexpression | GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN | 1.81e-04 | 194 | 111 | 6 | M7306 | |
| Coexpression | YU_MYC_TARGETS_DN | 2.01e-04 | 68 | 111 | 4 | MM632 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_VALVE_CELL_AGEING | 2.02e-04 | 126 | 111 | 5 | MM3709 | |
| Coexpression | MA_RAT_AGING_UP | 2.10e-04 | 127 | 111 | 5 | MM16096 | |
| Coexpression | GSE24972_WT_VS_IRF8_KO_MARGINAL_ZONE_SPLEEN_BCELL_UP | 2.13e-04 | 200 | 111 | 6 | M8097 | |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_DN | 2.13e-04 | 200 | 111 | 6 | M9327 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_DN | 2.13e-04 | 200 | 111 | 6 | M3638 | |
| Coexpression | KAECH_NAIVE_VS_DAY8_EFF_CD8_TCELL_DN | 2.13e-04 | 200 | 111 | 6 | M3013 | |
| Coexpression | NATSUME_RESPONSE_TO_INTERFERON_BETA_UP | 2.25e-04 | 70 | 111 | 4 | M6897 | |
| Coexpression | KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN | 2.64e-04 | 6 | 111 | 2 | M7182 | |
| Coexpression | GAURNIER_PSMD4_TARGETS | 2.65e-04 | 73 | 111 | 4 | M11428 | |
| Coexpression | WENG_POR_DOSAGE | 2.76e-04 | 30 | 111 | 3 | MM1199 | |
| Coexpression | DESCARTES_ORGANOGENESIS_WHITE_BLOOD_CELLS | 2.90e-04 | 615 | 111 | 10 | MM3641 | |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP | ATG10 HLA-A HLA-B HLA-C PATZ1 HLA-H ADCY7 ELOVL4 SEMA3B ETNK1 | 2.93e-04 | 616 | 111 | 10 | MM977 |
| Coexpression | TABULA_MURIS_SENIS_LUNG_NK_CELL_AGEING | 2.94e-04 | 75 | 111 | 4 | MM3759 | |
| Coexpression | TABULA_MURIS_SENIS_AORTA_PROFESSIONAL_ANTIGEN_PRESENTING_CELL_AGEING | 3.63e-04 | 143 | 111 | 5 | MM3673 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | ABR HLA-C TBC1D2 ABHD3 NLRP1 ZZEF1 ADCY7 CES2 SERPINA1 CACNA2D4 | 3.68e-04 | 634 | 111 | 10 | M40866 |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_B_CELL_AGEING | 4.13e-04 | 82 | 111 | 4 | MM3777 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_70PLS_NONRESPONDER_2DY_DN | 4.25e-04 | 148 | 111 | 5 | M40921 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_UP | 5.17e-04 | 87 | 111 | 4 | MM652 | |
| Coexpression | CASTELLANO_NRAS_TARGETS_UP | 5.40e-04 | 88 | 111 | 4 | MM1087 | |
| Coexpression | COATES_MACROPHAGE_M1_VS_M2_DN | 5.88e-04 | 90 | 111 | 4 | MM750 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_B_CELL_AGEING | 5.88e-04 | 90 | 111 | 4 | MM3756 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_FENESTRATED_CELL_AGEING | 6.13e-04 | 91 | 111 | 4 | MM3720 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_SMOOTH_MUSCLE_CELL_AGEING | 6.39e-04 | 92 | 111 | 4 | MM3748 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | IGSF8 HLA-A HLA-B PTCH1 ZZEF1 CES2 SLC30A6 SLC9A5 PLXNA1 XPOT | 6.42e-04 | 681 | 111 | 10 | M5314 |
| Coexpression | ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP | 6.66e-04 | 93 | 111 | 4 | M3889 | |
| Coexpression | JACKSON_DNMT1_TARGETS_UP | 6.66e-04 | 93 | 111 | 4 | MM1185 | |
| Coexpression | QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_EXPANSION_OF_VZV_SPECIFIC_T_CELLS_TO_PEAK_AT_1DY_POSITIVE | 6.68e-04 | 248 | 111 | 6 | M40874 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP | 6.70e-04 | 450 | 111 | 8 | M1350 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | ABR KIF21A ABHD3 PSD3 CHD7 PTCH1 GDA SV2A PLCL2 ETNK1 RCAN2 XPOT | 6.78e-04 | 946 | 111 | 12 | M39169 |
| ToppCell | COVID-19_Severe-CD8+_Tem|COVID-19_Severe / Disease condition and Cell class | 3.25e-08 | 195 | 111 | 8 | ff7ae62393e1c858a10592db8e6d9f36b8bae396 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.32e-07 | 103 | 111 | 6 | 3baaf23a9756be41af3a9b4f720e3ab00f1b674d | |
| ToppCell | Severe-CD4+_T_activated|Severe / Disease group and Cell class | 3.12e-07 | 177 | 111 | 7 | a08f170f1143fcdd7d0842a54d9b807a4548f8b7 | |
| ToppCell | Severe-CD4+_T_activated|World / Disease group and Cell class | 3.24e-07 | 178 | 111 | 7 | ef6111238703579a34bd6948bd9d4ca6b7e16063 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.76e-07 | 182 | 111 | 7 | f9c013075477e77a8373c73301a51e7e3f35369c | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.05e-07 | 184 | 111 | 7 | 15ea746c77785120f69f9ab370fb7eb9b70692f8 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.05e-07 | 184 | 111 | 7 | bd5e8fc453a6393b8778734a2c3c2f1281769bcd | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.36e-07 | 186 | 111 | 7 | 39e475a3c167b33daa63b0c1bfa32451c5f46635 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.36e-07 | 186 | 111 | 7 | 02418c50fdcca549bf73dedf6199ab4a27862a9b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-07 | 190 | 111 | 7 | 1cf023e3c6924d6a06f353d4b62444b6f2fee8a7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.21e-07 | 191 | 111 | 7 | 7235a4d1601c88a2c8af571a2c04ab56d32f1b9a | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Monocytic|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.21e-07 | 191 | 111 | 7 | 4d7f6216958fb202426b7a102e74682105ce7fca | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Classical_Monocyte|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.21e-07 | 191 | 111 | 7 | e979f6768065b8b3e522d66999ca794d844eccb4 | |
| ToppCell | Control-CD8+_Tem|Control / Disease condition and Cell class | 5.99e-07 | 195 | 111 | 7 | 7503b3e032f95b350a2782d28e4d412a8dc9ebcc | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.20e-07 | 196 | 111 | 7 | 6230b4a26770d30f1ab83345c087f03be1be0f9e | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.41e-07 | 197 | 111 | 7 | 2b3a56bb1d40bc1284a5931c4e7b373660de5402 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD8+_Tem|COVID-19_Severe / Disease group, lineage and cell class | 6.41e-07 | 197 | 111 | 7 | f0bac4d5c3160933ac3786cec8dadffb35d711ea | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.41e-07 | 197 | 111 | 7 | f73ece3aca28c0db5db0f12e026d42c6c36b9efb | |
| ToppCell | background-NK_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.41e-07 | 197 | 111 | 7 | e8e1d3e557fe821efe81012e759e35e4ae33ce86 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.41e-07 | 197 | 111 | 7 | e70e7d97823a762def3970d94a0e897981a6c922 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.41e-07 | 197 | 111 | 7 | bce0135a96910d2bace62a3408a1a6fdac0cf0df | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD8+_Tem|COVID-19_Severe / Disease, condition lineage and cell class | 7.09e-07 | 200 | 111 | 7 | 31859b8db7ea17e48b7b54e92f0d76aeb755e7ca | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.60e-06 | 143 | 111 | 6 | 5d5ba2717126a0d4e4464f3604cb282cb977d5b2 | |
| ToppCell | facs-Spleen-nan-24m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-06 | 156 | 111 | 6 | 034d4359359a44c205c6931f38a375271ac2752b | |
| ToppCell | facs-Spleen-nan-24m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-06 | 156 | 111 | 6 | 2a4dac4100c0339aad4905b8eaca6e8fe806718b | |
| ToppCell | facs-Spleen-nan-24m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-06 | 156 | 111 | 6 | 21267718d3a3dc19988663b6846aed8bb3eae836 | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-C_(Capillary_Aerocyte_)|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.75e-06 | 157 | 111 | 6 | 84f629b7f589ca8a1abc220fa740c4a6fdc1b579 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-06 | 159 | 111 | 6 | 7ad3a91d29639b32f6264c91f401c14a35469ac0 | |
| ToppCell | mild-Others-Megakaryocytes|Others / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.05e-06 | 95 | 111 | 5 | 74df0149882e2cd0d9aba0ef1ae4aac2cc1aeeac | |
| ToppCell | droplet-Spleen-nan-21m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-06 | 170 | 111 | 6 | 03cb4e508356f85372a588c8d1c6babf2a012683 | |
| ToppCell | droplet-Spleen-nan-21m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-06 | 171 | 111 | 6 | 9498c35b2a2c3a339dc8c5d49c8ec20d8ad52753 | |
| ToppCell | droplet-Spleen-nan-21m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-06 | 171 | 111 | 6 | db544252f98e073e5bb4bec4a110cd58e6434435 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.48e-06 | 177 | 111 | 6 | fd739ae4a574b72dc26a2a9ff4ef988454298ead | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.48e-06 | 177 | 111 | 6 | f35b04c3557ebbdeba37dec54c8f45880eafb422 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.63e-06 | 183 | 111 | 6 | 340621a8e720bd98da335f90598096833681834c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.63e-06 | 183 | 111 | 6 | 75da8c05b6d636f434c5684e0166fed0de3547b4 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.05e-06 | 185 | 111 | 6 | 7bff05d8d34616adbaa0ea0b69eb30aa906bb9f8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.05e-06 | 185 | 111 | 6 | 9438097e94219c1db922b8507e3a29106d32a923 | |
| ToppCell | LPS-IL1RA-Myeloid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.05e-06 | 185 | 111 | 6 | 9b5fd87ea9d05e051ff1251578ecfbe5e8652853 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-06 | 186 | 111 | 6 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.27e-06 | 186 | 111 | 6 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.97e-06 | 189 | 111 | 6 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.97e-06 | 189 | 111 | 6 | bfc76a72b600d641c8fe58346e5d8986c34f3981 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.21e-06 | 190 | 111 | 6 | 59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.21e-06 | 190 | 111 | 6 | 212f0d9defcc3174e225cc3d90e7814e238794b6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.21e-06 | 190 | 111 | 6 | b7f8c2bb9459f1d7c1690069dd5a25a81a57cc84 | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.46e-06 | 191 | 111 | 6 | 649fcb62ad15de2f83e61591e43923a717664ae7 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMH+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.46e-06 | 191 | 111 | 6 | b2d0ea24970da09209da9d9dda76e30fbfe22917 | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.46e-06 | 191 | 111 | 6 | 9621e22e14ea069f22713947c9faa2d882abe5fe | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.46e-06 | 191 | 111 | 6 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 8.46e-06 | 191 | 111 | 6 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | COVID-19-kidney-Myeloid|kidney / Disease (COVID-19 only), tissue and cell type | 8.72e-06 | 192 | 111 | 6 | 441cd1ec171f643b28e1f6f9c04def629cc7391b | |
| ToppCell | ILEUM-non-inflamed-(1)_Th17_Trm|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.72e-06 | 192 | 111 | 6 | 7347ff4dedd1aaa489c4f15e5ae647a4ce39ac72 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.72e-06 | 192 | 111 | 6 | fdc741e1846cfd8ed741b160e3c611c310c5d36d | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Cytotoxic_CD8+_T|metastatic_Lymph_Node / Location, Cell class and cell subclass | 9.25e-06 | 194 | 111 | 6 | 73c057b623829de793616d9d373a0018071d51d8 | |
| ToppCell | MS-CD8|MS / Condition, Cell_class and T cell subcluster | 9.25e-06 | 194 | 111 | 6 | 8dfeaa213403cedecb1976bfde1bac84f0155999 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.25e-06 | 194 | 111 | 6 | b04cbd240c59755ef7bdeb17fee3028caef6dedb | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 9.25e-06 | 194 | 111 | 6 | 777ce41c3f22c591e2d81120f189b834e53ffb4b | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.25e-06 | 194 | 111 | 6 | 607b5d194ba56efa9b106f10f89368fc103712a0 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.25e-06 | 194 | 111 | 6 | 744fd4580942183a1058717d0c3ac86483e366ed | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-CD8_TEM|Multiple_Sclerosis / Disease, Lineage and Cell Type | 9.25e-06 | 194 | 111 | 6 | fa53f1aab2f5923e90f090e10e3560b583441dc4 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.25e-06 | 194 | 111 | 6 | 95ab357d5f7bf91ba287417928c8575e655814fc | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.25e-06 | 194 | 111 | 6 | f5367072b259ae170cf0df3d4d871ab41be29d29 | |
| ToppCell | MS-CD8-CD8_1|MS / Condition, Cell_class and T cell subcluster | 9.25e-06 | 194 | 111 | 6 | 9c05eb30c4b5c6fc410b83cb8aa8138bd46527c9 | |
| ToppCell | BLOOD--(1)_T_cell-(1)_EM_CTLs|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.52e-06 | 195 | 111 | 6 | 7df67ad5c62235474ee56ea07a957253d45f066b | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 9.52e-06 | 195 | 111 | 6 | bff726515ea9ce82c223e6c805000afe2e9b7206 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.52e-06 | 195 | 111 | 6 | 1a7c2c4cf30df435770794a989be438579bf98f2 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.80e-06 | 196 | 111 | 6 | fe8d3f45a64323947c36b127355d5940eb56c0ca | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.80e-06 | 196 | 111 | 6 | ff88e5b919b1be93159ad2200a7786d1c5272724 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.80e-06 | 196 | 111 | 6 | 526d037bb12d81f1c235c60ddc787fbad0bbad77 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.01e-05 | 197 | 111 | 6 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | COVID-19_Moderate-CD8+_Tem|World / disease group, cell group and cell class | 1.04e-05 | 198 | 111 | 6 | 1d12be256af028c88e31fb535068bae16b7bd48e | |
| ToppCell | (2)_NK/T-(20)_NK_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 1.04e-05 | 198 | 111 | 6 | 2e4851e49457940e841660c5d781499ffb4a2bf1 | |
| ToppCell | Fetal_29-31_weeks-Immune|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.04e-05 | 198 | 111 | 6 | 5dff131356b8c22743bd27b2b21f86ee6e4a0a0d | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-05 | 198 | 111 | 6 | cc2b5b632e73e44bb60050f0db10d8f0dbb859fa | |
| ToppCell | Caecum-(6)_Macrophage-(61)_LYVE1_Macrophage|Caecum / shred on region, Cell_type, and subtype | 1.04e-05 | 198 | 111 | 6 | e684c3934c163aef4d284b69435832d2c9614f2a | |
| ToppCell | (2)_NK/T-(200)_CD56+_NK_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 1.04e-05 | 198 | 111 | 6 | 03477a6356a3c08c6e723165c0aac3464ef01667 | |
| ToppCell | Caecum-Macrophage-LYVE1_Macrophage|Caecum / Region, Cell class and subclass | 1.04e-05 | 198 | 111 | 6 | a92c0cacb775aca6bbb302bd9e22c081a112a44d | |
| ToppCell | MS-IIF-Myeloid-pDC|IIF / Disease, condition lineage and cell class | 1.07e-05 | 199 | 111 | 6 | e262ee854e64d87460bee810c14d6cbe744460e8 | |
| ToppCell | 5'-Adult|5' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-05 | 199 | 111 | 6 | 8b7b1fcea9a06522fdfab85d0dfd33010ae96d75 | |
| ToppCell | Goblet_3|World / shred by cell class for nasal brushing | 1.07e-05 | 199 | 111 | 6 | 4229a17a3a6d8855655acc0a1c8704166f8e74c0 | |
| ToppCell | CTRL-Myeloid|CTRL / Disease state, Lineage and Cell class | 1.07e-05 | 199 | 111 | 6 | 70b89a930709fdb91fde6f96106add8455b11618 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-05 | 199 | 111 | 6 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.07e-05 | 199 | 111 | 6 | da7cf363712ecec4fb90e3881eb585b7eea13fe7 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.07e-05 | 199 | 111 | 6 | 9da8b48ec1c1c105fcbab6ae8f08166e7d5e8a35 | |
| ToppCell | COVID-19-lung|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.07e-05 | 199 | 111 | 6 | 155b03b859157013e9142e9248551369127d9204 | |
| ToppCell | Biopsy_IPF-Epithelial-SCGB3A2+|Biopsy_IPF / Sample group, Lineage and Cell type | 1.10e-05 | 200 | 111 | 6 | 2aaf130d702d18c277d16b6800f006a53ed653fb | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_submucosal-gland-SMG_Serous|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-05 | 200 | 111 | 6 | 61bae10c8b12196d9cee766897971b81cb897191 | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-MAIT|Multiple_Sclerosis / Disease, condition lineage and cell class | 1.10e-05 | 200 | 111 | 6 | 10120f474ac3de10fc8e66158969415bd3f8c1da | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-CD8+_Tem|Multiple_Sclerosis / Disease, condition lineage and cell class | 1.10e-05 | 200 | 111 | 6 | cba63f8f2e7530e5539f7f5d93b3bcf5d693f6b9 | |
| ToppCell | PBMC-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters | 2.09e-05 | 133 | 111 | 5 | e53fbd69775a4bff61de82557342f7ac80915c4d | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.76e-05 | 141 | 111 | 5 | 9f26b2a5ccdf8762f16b673e59543b694fbacc10 | |
| ToppCell | (5)_Plasma-(5)_Plasma_IgG|(5)_Plasma / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.84e-05 | 70 | 111 | 4 | bfe020c111a27337ed4dc6ee59b74bc36b03eb49 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.06e-05 | 144 | 111 | 5 | 1b9e95e4f6e40042d3cf2f94c067f3a6b19428ea | |
| ToppCell | BLOOD--(0)_NK_cell-(0)_NK_cells_(CD56dim-like)|(0)_NK_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.16e-05 | 145 | 111 | 5 | 6dd81d53d006fcc206a10969374a11c372f92133 | |
| ToppCell | (07)_Ionocytes-(1)_GFP|(07)_Ionocytes / shred by cell type by condition | 3.37e-05 | 147 | 111 | 5 | d398f49553ece2786c51e16e4bee028fb3833149 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.21e-05 | 154 | 111 | 5 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.21e-05 | 154 | 111 | 5 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | PND07-28-samps|World / Age Group, Lineage, Cell class and subclass | 4.62e-05 | 157 | 111 | 5 | a2005768a6d268879e3fd6dbd8cf674dc98be587 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.62e-05 | 157 | 111 | 5 | eea53cf8d8a607264e1ee00b7a97c94bcf2ac80d | |
| Computational | Genes in the cancer module 293. | 5.34e-05 | 12 | 69 | 3 | MODULE_293 | |
| Computational | Genes in the cancer module 143. | 8.76e-05 | 14 | 69 | 3 | MODULE_143 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.87e-04 | 50 | 69 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_10_PROTEIN_MATURATION | |
| Disease | graft-versus-host disease (implicated_via_orthology) | 1.70e-06 | 7 | 109 | 3 | DOID:0081267 (implicated_via_orthology) | |
| Disease | beta-2 microglobulin measurement | 7.92e-06 | 11 | 109 | 3 | EFO_0005197 | |
| Disease | – | 1.35e-05 | 2 | 109 | 2 | 608579 | |
| Disease | Susceptibility to severe cutaneous adverse reaction | 1.35e-05 | 2 | 109 | 2 | cv:C1840548 | |
| Disease | Carbamazepine response | 1.35e-05 | 2 | 109 | 2 | cv:CN077964 | |
| Disease | Drug toxicity | 1.53e-05 | 84 | 109 | 5 | C0013221 | |
| Disease | Adverse reaction to drug | 1.53e-05 | 84 | 109 | 5 | C0041755 | |
| Disease | epilepsy (implicated_via_orthology) | 3.28e-05 | 163 | 109 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | HIV Infections | 4.12e-05 | 103 | 109 | 5 | C0019693 | |
| Disease | HIV Coinfection | 4.12e-05 | 103 | 109 | 5 | C4505456 | |
| Disease | amino acid metabolic disorder (implicated_via_orthology) | 8.07e-05 | 4 | 109 | 2 | DOID:9252 (implicated_via_orthology) | |
| Disease | Stevens-Johnson syndrome (is_implicated_in) | 8.07e-05 | 4 | 109 | 2 | DOID:0050426 (is_implicated_in) | |
| Disease | Ulcerative Colitis | 8.87e-05 | 63 | 109 | 4 | C0009324 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.07e-04 | 291 | 109 | 7 | EFO_0008317, EFO_0020946 | |
| Disease | Malignant Glioma | 1.34e-04 | 70 | 109 | 4 | C0555198 | |
| Disease | mixed gliomas | 1.34e-04 | 70 | 109 | 4 | C0259783 | |
| Disease | allergic asthma (is_implicated_in) | 1.34e-04 | 5 | 109 | 2 | DOID:9415 (is_implicated_in) | |
| Disease | Drug-Induced Stevens Johnson Syndrome | 1.67e-04 | 29 | 109 | 3 | C1274933 | |
| Disease | Mycoplasma-Induced Stevens-Johnson Syndrome | 1.67e-04 | 29 | 109 | 3 | C3658301 | |
| Disease | Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum | 1.67e-04 | 29 | 109 | 3 | C3658302 | |
| Disease | Toxic Epidermal Necrolysis | 1.67e-04 | 29 | 109 | 3 | C0014518 | |
| Disease | comparative body size at age 10, self-reported | 1.71e-04 | 420 | 109 | 8 | EFO_0009819 | |
| Disease | Stevens-Johnson Syndrome | 1.85e-04 | 30 | 109 | 3 | C0038325 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 1.94e-04 | 225 | 109 | 6 | EFO_0008317, EFO_0010351 | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 2.66e-04 | 153 | 109 | 5 | EFO_0004611, EFO_0020944 | |
| Disease | Glioma | 3.10e-04 | 87 | 109 | 4 | C0017638 | |
| Disease | serum albumin measurement | 3.57e-04 | 592 | 109 | 9 | EFO_0004535 | |
| Disease | basal cell carcinoma (is_marker_for) | 3.73e-04 | 8 | 109 | 2 | DOID:2513 (is_marker_for) | |
| Disease | human immunodeficiency virus infectious disease (is_implicated_in) | 4.07e-04 | 39 | 109 | 3 | DOID:526 (is_implicated_in) | |
| Disease | body fat percentage | 4.67e-04 | 488 | 109 | 8 | EFO_0007800 | |
| Disease | advanced glycation end-product measurement | 4.79e-04 | 9 | 109 | 2 | EFO_0007819 | |
| Disease | Proteinuria | 5.43e-04 | 43 | 109 | 3 | C0033687 | |
| Disease | visceral:gluteofemoral adipose tissue ratio measurement | 6.21e-04 | 45 | 109 | 3 | EFO_0803319 | |
| Disease | Ankylosing spondylitis | 7.28e-04 | 11 | 109 | 2 | C0038013 | |
| Disease | cocaine use measurement | 7.28e-04 | 11 | 109 | 2 | EFO_0010553 | |
| Disease | Centriacinar Emphysema | 8.71e-04 | 12 | 109 | 2 | C0221227 | |
| Disease | Panacinar Emphysema | 8.71e-04 | 12 | 109 | 2 | C0264393 | |
| Disease | Focal Emphysema | 8.71e-04 | 12 | 109 | 2 | C2350878 | |
| Disease | lymphocyte measurement | 9.48e-04 | 117 | 109 | 4 | EFO_0803546 | |
| Disease | cirrhosis of liver | 1.03e-03 | 13 | 109 | 2 | EFO_0001422 | |
| Disease | essential hypertension, age at diagnosis | 1.18e-03 | 56 | 109 | 3 | EFO_0004918, MONDO_0001134 | |
| Disease | osteoprotegerin measurement | 1.20e-03 | 14 | 109 | 2 | EFO_0005918 | |
| Disease | apolipoprotein A 1 measurement | CYP2A6 HLA-B PSD3 CES2 SLC9A5 SLC12A3 APLNR CTBP2 CDH1 MAP2K6 | 1.20e-03 | 848 | 109 | 10 | EFO_0004614 |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.24e-03 | 215 | 109 | 5 | EFO_0008317, EFO_0008591 | |
| Disease | Endometrial Neoplasms | 1.31e-03 | 58 | 109 | 3 | C0014170 | |
| Disease | refractive error | 1.36e-03 | 326 | 109 | 6 | MONDO_0004892 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 1.37e-03 | 220 | 109 | 5 | EFO_0004529, EFO_0008317 | |
| Disease | killer cell immunoglobulin-like receptor 2DS2 measurement | 1.38e-03 | 15 | 109 | 2 | EFO_0801746 | |
| Disease | nose morphology measurement | 1.42e-03 | 329 | 109 | 6 | EFO_0007843 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.49e-03 | 224 | 109 | 5 | EFO_0004574, EFO_0008317 | |
| Disease | psoriasis vulgaris | 1.51e-03 | 61 | 109 | 3 | EFO_1001494 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 1.51e-03 | 225 | 109 | 5 | EFO_0008317, EFO_0020947 | |
| Disease | developmental dysplasia of the hip | 1.57e-03 | 16 | 109 | 2 | EFO_1000648 | |
| Disease | Schizoaffective disorder-bipolar type | 1.57e-03 | 16 | 109 | 2 | EFO_0009965 | |
| Disease | methylcobalamin deficiency type cblE, brain serotonin transporter measurement | 1.57e-03 | 16 | 109 | 2 | EFO_0004569, MONDO_0009354 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 1.64e-03 | 229 | 109 | 5 | EFO_0004639, EFO_0008317 | |
| Disease | serum IgE measurement | 1.73e-03 | 64 | 109 | 3 | EFO_0004579 | |
| Disease | Pulmonary Emphysema | 1.77e-03 | 17 | 109 | 2 | C0034067 | |
| Disease | partial epilepsy | 1.77e-03 | 17 | 109 | 2 | EFO_0004263 | |
| Disease | eosinophil percentage of leukocytes | 1.81e-03 | 746 | 109 | 9 | EFO_0007991 | |
| Disease | phospholipid measurement | 1.84e-03 | 140 | 109 | 4 | EFO_0004639 | |
| Disease | essential hypertension (is_implicated_in) | 1.99e-03 | 18 | 109 | 2 | DOID:10825 (is_implicated_in) | |
| Disease | basophil count | 2.14e-03 | 483 | 109 | 7 | EFO_0005090 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 2.36e-03 | 364 | 109 | 6 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | Endometrial Carcinoma | 2.43e-03 | 72 | 109 | 3 | C0476089 | |
| Disease | Hemorrhage | 2.46e-03 | 20 | 109 | 2 | C0019080 | |
| Disease | ulcerative colitis, Crohn's disease | 2.46e-03 | 20 | 109 | 2 | EFO_0000384, EFO_0000729 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.54e-03 | 153 | 109 | 4 | EFO_0004611, EFO_0020946 | |
| Disease | COVID-19 (is_implicated_in) | 2.71e-03 | 21 | 109 | 2 | DOID:0080600 (is_implicated_in) | |
| Disease | osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty | 2.71e-03 | 21 | 109 | 2 | EFO_0004616, EFO_0010726, EFO_1000786 | |
| Disease | Nephritis, Tubulointerstitial | 2.71e-03 | 21 | 109 | 2 | C0041349 | |
| Disease | non-small cell lung carcinoma | 2.73e-03 | 75 | 109 | 3 | EFO_0003060 | |
| Disease | total iron binding capacity | 3.05e-03 | 78 | 109 | 3 | EFO_0006334 | |
| Disease | Nephritis, Interstitial | 3.54e-03 | 24 | 109 | 2 | C0027707 | |
| Disease | lung squamous cell carcinoma (is_implicated_in) | 3.54e-03 | 24 | 109 | 2 | DOID:3907 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VDYTKEDKTFFGAFL | 236 | O95150 | |
| FGYFVSKAKTRVFRD | 531 | Q12979 | |
| IFFFGSDFENYIKTI | 136 | P20292 | |
| RDFFKYVELSTFDIA | 166 | Q9H9S4 | |
| IDGFVYSFIIKDRSY | 321 | Q8NDM7 | |
| AVRAKAFGFSVIFYD | 196 | P56545 | |
| VISSIVFGDRFDYKD | 181 | P11509 | |
| DRDTVFALVNYIFFK | 201 | P01009 | |
| DNFSFSAKIRVGDFY | 801 | Q9UIF8 | |
| DFASFLEFVYTAKVQ | 86 | Q9H116 | |
| FVVYDGALFFNKERT | 211 | Q9HAR2 | |
| RAFDLYFVLDKSGSV | 41 | P58335 | |
| IREFDKRFTSVMFGY | 301 | Q8WU67 | |
| ADYVAKSGFFRVFIG | 196 | Q9Y6Z7 | |
| FIGEKTFQRYCAEFI | 6 | Q9H0Y0 | |
| FRDFQFKKTGAIYDA | 326 | P46597 | |
| TFGSIFLEKGFEREY | 571 | P51828 | |
| EADFYRVVSTFGVIF | 1971 | Q9P2D1 | |
| YLAFTDLEFKTEFIG | 781 | Q96BY7 | |
| KFEGLFRTYDDCVTF | 31 | Q14206 | |
| DGFLIVYSVTDKASF | 86 | O14807 | |
| YKEAVGAFVVFDISR | 96 | Q13637 | |
| VGKTSFLFRYADDSF | 41 | Q96E17 | |
| FISVGYVDDTQFVRF | 46 | P01893 | |
| YFFIAQTIAGHFRKE | 221 | P35414 | |
| ISIRVDAAFQYKGFF | 421 | Q9H306 | |
| FFSRGSKQFEYDIKT | 436 | Q9H306 | |
| FFKSDLETYVARSVG | 216 | Q3ZCV2 | |
| LEGAKTFFRDLSAVY | 1431 | Q71F56 | |
| YFVSKGVEYLDTVFF | 131 | Q9GZR5 | |
| KSYDETVDIFSFGIV | 521 | P53671 | |
| IAFVEKSGYRFEVSF | 71 | Q8WXJ9 | |
| KSGYRFEVSFNLDFT | 76 | Q8WXJ9 | |
| RFTGATIFEEYARKA | 241 | Q9BZQ6 | |
| FITRFAVNGKFVYVD | 371 | Q8WYA1 | |
| FISVGYVDDTQFVRF | 46 | P10321 | |
| SNESAIDFYRKFGFE | 116 | Q9GZZ1 | |
| ETGKKFASVDFVFYN | 646 | Q9UIW2 | |
| VEVLGFSESSRKEYF | 476 | Q9C000 | |
| RSFFGGNYIKFTEEE | 466 | O00748 | |
| RYKESFVSAGFASFD | 941 | P54753 | |
| QFYEIKAGEEFRSFK | 591 | Q9BSC4 | |
| RTEVSEFFLKGFSGY | 6 | Q8NGT2 | |
| RKLFGFTERYGAVFS | 506 | Q96FC9 | |
| FISVGYVDDTQFVRF | 46 | P01889 | |
| EGVDFYKSITRARFE | 291 | P48741 | |
| DFFGKISSFIRKYDA | 296 | Q96MD2 | |
| REKSYLFDVAFDFTA | 61 | Q2TAC6 | |
| SKVFGDILDFAYTSR | 111 | Q9HBE1 | |
| AAFESARIYAATFEK | 606 | Q9C0G6 | |
| FSYAVFKSRVVAGEV | 86 | Q969P0 | |
| EAFVRFFVEIVGHYS | 901 | Q9ULE3 | |
| KTAFYLAEFFVNEAR | 266 | Q92820 | |
| FVAEKYGFIDLSRVA | 711 | Q86TI2 | |
| GKRVLFLTNDYFFTD | 626 | Q7Z3S7 | |
| YDNGIKFAFTFELRD | 371 | Q9UI42 | |
| KFAFTFELRDTGTYG | 376 | Q9UI42 | |
| SKLFTVDFYFEEVQR | 76 | Q96A23 | |
| KGIVYAVSSDRFRSF | 66 | O43602 | |
| FGFALTFYEEVTSKQ | 131 | Q6IQ26 | |
| FIAVGYVDDTQFVRF | 46 | P04439 | |
| FFGDISEAVIQKFLY | 416 | Q9Y2T3 | |
| VVVGTDKSFTYDFVF | 41 | O95239 | |
| VVVGTDKSFTYDFVF | 41 | Q2VIQ3 | |
| SKYVVGRALDFATSF | 3876 | Q9NYC9 | |
| STIEFDFLGYAIVRF | 421 | Q9HBU6 | |
| SFYAFEVKDAKGRTV | 46 | Q8TED1 | |
| GRFTREDPTFKVYFD | 471 | Q96RP9 | |
| STDYFLSSGDKIRFF | 66 | Q5SRE7 | |
| TAYFSLDTRFKVGTD | 66 | P12830 | |
| EYFSALRDFVKTFTA | 66 | Q96EK7 | |
| TFEDATDFFGRVVIY | 116 | Q86WQ0 | |
| YSFVTEENTFEVKLF | 1491 | Q12923 | |
| SFRVDNKRFYFDVGS | 266 | Q9UJV8 | |
| FTVTFYGALFREGDV | 111 | P52564 | |
| NEILTFKVDYGSFAF | 296 | Q9Y6R4 | |
| FKVDYGSFAFVRDRA | 301 | Q9Y6R4 | |
| VFKDRDKYVSGEFRF | 216 | Q9BRS2 | |
| VSQAVITDGKYFSFF | 356 | Q9NP92 | |
| KYALQVSSEFFEEGF | 711 | A2RTX5 | |
| DFLRTVYSVFGFSFK | 481 | P26639 | |
| FSRFFSYFRGVEVTD | 116 | Q16518 | |
| KDFIYFTVFEGNVRN | 81 | Q68CR1 | |
| KVFFVDFGNIYVVTS | 1061 | O60522 | |
| GFGFVRFTEYETQVK | 146 | Q13148 | |
| FSEAIRFNADYGVFE | 41 | Q8NE09 | |
| LGATFIRKFYTEFDR | 381 | P00797 | |
| FRSVIDIINKYAFFA | 496 | Q9UPR0 | |
| AGSEFDFIVRYFFAV | 1141 | Q13635 | |
| KYGTLQEFSFFDKVR | 301 | O75182 | |
| AFVIVAGVFAKVSYD | 186 | Q6ZSJ9 | |
| AKDYFVATTIVVVFF | 426 | Q14940 | |
| YETSVFDQFGIKDVF | 186 | O94844 | |
| RYEFFDGEVKSSIFF | 696 | P40879 | |
| VFSYFSEFLAQEKRG | 276 | Q7L0J3 | |
| FEYDKSLGSTRFFKV | 26 | Q99570 | |
| GTDLSIFKYDDFIFV | 401 | Q96JG6 | |
| GEYITKVFVAFQAFL | 116 | Q96DA0 | |
| RGCVVFEDVFVYFSR | 46 | Q8TAW3 | |
| VFLGKDKAFTFDYVF | 41 | Q7Z4S6 | |
| KIYFFFRETAVEAAP | 241 | Q13214 | |
| ISFFSERKYLQGFVA | 246 | P47872 | |
| LFVIVGFAAFAYTVK | 236 | Q8N2K1 | |
| YTEVAIVVKYFFQFG | 1971 | Q9H5I5 | |
| DKASKGFFSYRADIF | 311 | P55017 | |
| VYSFGFERLEVLAVF | 91 | Q6NXT4 | |
| DYFISSVFERFKVVD | 726 | Q6ZT12 | |
| EFFETVVRYEKFFTV | 501 | O43592 | |
| KTDYFFLEVQKRFDG | 2491 | O43149 | |
| RGFKETAFLYAVSSA | 111 | O14905 | |
| LRYFFKAFSLVGETQ | 636 | Q9NYI0 | |
| DAFLYEGTKVVFRYA | 811 | Q9BYX2 | |
| TRYTAAKDSVVQFFF | 321 | P82987 | |
| ISLEEGFFKVDYSQF | 331 | P48549 | |
| YSVEGFIDKNRDFLF | 526 | B0I1T2 | |
| RFGFSLYIALFDKVS | 1296 | Q13402 | |
| FEGLTDFSDTFKLYR | 1491 | Q9NZM1 |